Cambridge, MA, United States of America

Erika Ellen Johnston

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.7

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Erika Ellen Johnston

Introduction

Erika Ellen Johnston is a notable inventor based in Cambridge, MA (US). She has made significant contributions to the field of particle technology, holding a total of 3 patents. Her work focuses on the development of advanced apparatuses and methods for the formation and application of particles.

Latest Patents

One of her latest patents is titled "Apparatuses and methods for formation of particles." This patent describes apparatuses and methods for conditioning particles, specifically designed for first-in-first-out transit of particles through a chamber containing a conditioning fluid. The innovations enable the manufacture of particle preparations that contain large quantities of particles, such as cell-containing particles, with more consistent and improved properties compared to alternative manual processes. Another significant patent is "Implantable particles and related methods," which details particles comprising a first compartment, a second compartment, and a compound of Formula (I). This invention includes compositions and methods for creating particles that may contain cells capable of expressing therapeutic agents useful for treating various diseases, disorders, or conditions.

Career Highlights

Erika Johnston is currently associated with Sigilon Therapeutics, Inc., where she continues to advance her research and innovations in particle technology. Her work has the potential to impact various medical applications, particularly in the field of therapeutics.

Collaborations

Erika collaborates with esteemed colleagues, including Robert James Miller and Michael Beauregard, who contribute to her research endeavors and innovations.

Conclusion

Erika Ellen Johnston's contributions to particle technology through her patents and work at Sigilon Therapeutics, Inc. highlight her role as a leading inventor in her field. Her innovative approaches are paving the way for advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…